Düsseldorf (Reuters) - Der Leverkusener Bayer-Konzern hat sich von einem Teil seiner Aktien des US-Tiergesundheitsunternehmen Elanco Animal Health getrennt. 54,5 Millionen Elanco-Aktien seien am ...

After an acquisition of Bayer Animal Health in 2020, Elanco has made progress in paying down debt. Robust pipeline with six potential blockbuster products to be launched in 2024 and 2025. Improving ...

Elanco Animal Health (ELAN) said it has been granted antitrust clearance by the European Commission to buy Bayer AG’s veterinary health unit after agreeing to divest a number of their products to meet ...

Elanco has closed its $7.6 billion acquisition of Bayer Animal Health. Elanco CEO Jeff Simmons joins Yahoo Finance’s Brian Sozzi and Alexis Christoforous to discuss. ALEXIS CHRISTOFOROUS: All right, ...

INDIANAPOLIS (AP) — Elanco Animal Health will spend $7.6 billion to acquire Bayer AG’s veterinary medicines business, which would make it the second-largest animal health company. Elanco said Tuesday ...

Elanco Animal Health Inc ELAN shares were trading lower Tuesday after the company announced it would acquire Bayer AG BAYRY's animal health business for $5.32 billion in cash and $2.28 billion in ...

Feb 29 (Reuters) - Investment firm Ancora Holdings is pushing for four board seats at Elanco Animal Health ELAN.N and wants to replace the chief executive at the company that makes medicines and ...

Elanco Animal Health said on Wednesday the U.S. Department of Agriculture (USDA) has approved its canine flu vaccine, which offers dogs protection against serious respiratory disease. November 12, ...

Across the recent three months, 5 analysts have shared their insights on Elanco Animal Health (NYSE:ELAN), expressing a variety of opinions spanning from bullish to bearish. The following table ...

Elanco Animal Health Inc. said Monday it plans to restructure operations, which will result in the loss of 420 jobs. The Greenfield-based maker of vaccines, antibiotics and other animal-health ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches, despite a 20.5% stock decline since August 2024. The stock drop is mainly due to safety risks with the ...